Literature DB >> 34933960

Cancer-Specific Mortality in Asian American Women Diagnosed with Gynecologic Cancer: A Nationwide Population-Based Analysis.

Pritesh S Karia1, Parisa Tehranifar1,2, Kala Visvanathan3,4,5, Jason D Wright2,6, Jeanine M Genkinger1,2.   

Abstract

BACKGROUND: Cancer is the leading cause of death in Asian Americans (AA), the fastest-growing U.S. population group. Despite heterogeneity in socioeconomic status and health behaviors by ethnicity, few studies have assessed cancer outcomes across AA ethnic groups. We examined differences in gynecologic cancer mortality between AA ethnic groups and non-Hispanic Whites (NHW).
METHODS: Using the Surveillance, Epidemiology, and End Results database, we identified ovarian (n = 69,113), uterine (n = 157,340), and cervical cancer cases (n = 41,460) diagnosed from 1991-2016. Competing risk regression was used to compare cancer-specific mortality for AAs by ethnicity, using NHW as the reference population.
RESULTS: In adjusted analyses, AAs had a lower risk of ovarian [HR, 0.90; 95% confidence interval (CI), 0.86-0.94] and cervical cancer death (HR, 0.80; 95% CI, 0.75-0.87) than NHWs, with stronger associations among those ≥50 years at diagnosis [(HRovary, 0.87; 95% CI, 0.82-0.92); (HRcervix, 0.74; 95% CI, 0.67-0.81)]. No overall difference was noted for uterine cancer death (HR, 1.03; 95% CI, 0.97-1.10); however, AAs <50 years at diagnosis had a higher risk of uterine cancer death than NHWs (HR, 1.26; 95% CI, 1.08-1.46). Patterns of cancer mortality were heterogeneous, with Filipino and Chinese women at the highest risk of uterine cancer death and Indian/Pakistani women at the lowest risk of ovarian and cervical cancer death.
CONCLUSIONS: There are significant differences in gynecologic cancer mortality between AAs and NHWs, with heterogeneity by AA ethnicity. IMPACT: Disaggregated analysis of AA is needed to better understand the burden of gynecologic cancer and identify high-risk groups for cancer prevention efforts. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 34933960      PMCID: PMC8901555          DOI: 10.1158/1055-9965.EPI-21-0829

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  49 in total

1.  Distinctive clinicopathologic characteristics and prognosis for different histologic subtypes of early cervical cancer.

Authors:  Lijie Cao; Hao Wen; Zheng Feng; Xiaotian Han; Xiaohua Wu
Journal:  Int J Gynecol Cancer       Date:  2019-08-17       Impact factor: 3.437

Review 2.  Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology.

Authors:  Yvonne Collins; Kevin Holcomb; Eloise Chapman-Davis; Dineo Khabele; John H Farley
Journal:  Gynecol Oncol       Date:  2014-01-07       Impact factor: 5.482

3.  Factors associated with missing birthplace information in a population-based cancer registry.

Authors:  S S Lin; C D O'Malley; S W Lui
Journal:  Ethn Dis       Date:  2001       Impact factor: 1.847

4.  Racial/Ethnic Disparities in Ovarian Cancer Treatment and Survival.

Authors:  Elisa V Bandera; Valerie S Lee; Lorna Rodriguez-Rodriguez; C Bethan Powell; Lawrence H Kushi
Journal:  Clin Cancer Res       Date:  2016-08-12       Impact factor: 12.531

5.  Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000.

Authors:  Gopal K Singh; Barry A Miller; Benjamin F Hankey; Brenda K Edwards
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

6.  Epidemiology and clinicopathology of breast cancer in metro Manila and Rizal Province, Philippines.

Authors:  Adriano Laudico; Maria Theresa M Redaniel; Maria Rica Mirasol-Lumague; Cynthia A Mapua; Gemma B Uy; Eero Pukkala; Paola Pisani
Journal:  Asian Pac J Cancer Prev       Date:  2009 Jan-Mar

7.  Ovarian cancer, version 3.2012.

Authors:  Robert J Morgan; Ronald D Alvarez; Deborah K Armstrong; Robert A Burger; Mariana Castells; Lee-may Chen; Larry Copeland; Marta Ann Crispens; David Gershenson; Heidi Gray; Ardeshir Hakam; Laura J Havrilesky; Carolyn Johnston; Shashikant Lele; Lainie Martin; Ursula A Matulonis; David M O'Malley; Richard T Penson; Steven W Remmenga; Paul Sabbatini; Joseph T Santoso; Russell J Schilder; Julian Schink; Nelson Teng; Theresa L Werner; Miranda Hughes; Mary A Dwyer
Journal:  J Natl Compr Canc Netw       Date:  2012-11-01       Impact factor: 11.908

8.  Cancer Mortality in U.S.-Born versus Foreign-Born Asian American Groups (2008-2017).

Authors:  Osika Tripathi; Yuelin He; Bridgette Y Han; Darynn G Paragas; Nora Sharp; Shozen Dan; Malathi Srinivasan; Latha P Palaniappan; Caroline A Thompson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-10-25       Impact factor: 4.090

9.  Years of life lost as a measure of cancer burden on a national level.

Authors:  O T Brustugun; B Møller; A Helland
Journal:  Br J Cancer       Date:  2014-07-01       Impact factor: 7.640

10.  Comparison of SEER Treatment Data With Medicare Claims.

Authors:  Anne-Michelle Noone; Jennifer L Lund; Angela Mariotto; Kathleen Cronin; Timothy McNeel; Dennis Deapen; Joan L Warren
Journal:  Med Care       Date:  2016-09       Impact factor: 3.178

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.